The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center. All the Verso Healthcare teams
IMP360, a subsidiary of the Verso Healthcare group, was present at the first edition of the MIMS Health Innovation Forum, which took place on 8 and 9 December at the Futuroscope Convention Centre in Poitiers.On
After obtaining and renewing in 2021 its ISO27001 and HDS certifications for its health data hosting activities, 123 CS, a subsidiary of the Verso Healthcare group, is now “ExpertCyber” certified. This new recognition is in
After being certified ISO 27001 and HDS, 123CS, a subsidiary of the Verso Healthcare group, a cybersecurity provider and health data host, has joined the national platform “cybermalveillance.gouv.fr”.By signing this charter, 123CS commits to respecting
123CS, una filiale del gruppo Verso Healthcare, viene premiata all’inizio dell’anno dal media specializzato GRC Viewpoint. L’opportunità per Laurent DERTIN, direttore di 123CS ed esperto, di tornare alle sfide della sicurezza informatica nel campo della
The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center. All the Verso Healthcare teams
Per supportare i forti impegni e la crescita del gruppo a livello internazionale, Verso Healthcare è lieta di annunciare che David DESPRETZ si unisce al gruppo come Chief Commercial Officer, riportando direttamente al Presidente del
After having been awarded in 2021, the ExpertCyber label delivered by the French State, 123CS has just joined the Alliance for Digital Confidence (ACN) and obtained the ECSO Cybersecurity Made in Europe label. The Alliance
Fin d’année 2021 soutenue et fortes perspectives de développement et de croissance pour 2022, tels sont les messages forts de Christophe Sicot, Président et Fondateur du groupe Verso Healthcare exprimés à l’occasion d’une interview récente
